Skip to content

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Systemic inflammation, statin therapy, and clinical outcomes in heart failure: a territory-wide population-based cohort study

Inflammation is increasingly recognized as an important modifier of prognosis in heart failure (HF). However, whether the association between statin therapy and outcomes varies by inflammatory risk and treatment duration remains uncertain. To evaluate the association between statin therapy and clinical out...

A. Cai, Wen-Li Gu, K. Yiu · 0 citations
Open access Oct 2026

Long-term outcomes of combined significant aortic regurgitation and mitral regurgitation versus isolated aortic regurgitation

Combined aortic regurgitation (AR) and mitral regurgitation (MR) is a relatively common multiple valvular heart disease. Current guidelines recommend intervention (AVI and/or MVI) when either lesion becomes severe in the setting of symptoms, left ventricular (LV) systolic dysfunction or dilation, as in isolated s...

C. Ng, P. Santi, N. Elmasry et al. · 0 citations
Open access Oct 2026

Cellular deep proteomic profiling elucidates NLRP3 inflammasome and immunothrombosis effects of GLP-1 receptor agonist: a controlled intervention study

GLP-1 receptor agonists confer pleiotropic vascular protection via mechanisms other than glycemic and body weight control. Comprehensive proteomic evaluations of its immunothrombosis modulatory and vascular effects remained limited. To investigate the immunothrombosis modulatory effects of GLP-1 receptor a...

Y. Chan, S. Rakesh, T. Chan et al. · 0 citations
Open access Oct 2026

Increased left atrial pressure in chronic aortic regurgitation: association with outcomes

Among asymptomatic patients with moderate-severe or severe chronic AR and preserved LVEF, elevated LAP is independently associated with increased long-term mortality, suggesting that markers of elevated LV filling pressures may improve risk stratification of these patients.

P. Santi, N. Elmasry, J. Bernard et al. · 0 citations
Open access Oct 2026

Lipid management in patients with coronary artery disease at risk of a first major atherosclerotic cardiovascular event: findings from the VESALIUS-REAL global study

In this large, global, real-world study, most patients with CAD at risk of a first MACE were undertreated with LLT and did not achieve recommended LDL-C levels, highlighting substantial gaps between guideline recommendations and real-world practice.

Q. Chan, J. Cegla, J. Cornel et al. · 0 citations
Open access Oct 2026

U-shaped association of HbA1c levels with incident cancer risk in patients with heart failure and type 2 diabetes mellitus

Patients with concurrent heart failure (HF) and type 2 diabetes mellitus (T2DM) have a markedly elevated cancer risk, yet the optimal glycemic control target for reducing oncologic risk in this population is unclear. Nonlinear relationships between glycemic markers and cancer outcomes have been suggested, but thi...

Y. Qi, Q. Ren, A. Mastumoto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.